Sigma Planning Corp’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,199
Closed -$249K 1402
2021
Q4
$249K Sell
3,199
-1,885
-37% -$166K 0.01% 1173
2021
Q3
$485K Sell
5,084
-266
-5% -$28.1K 0.01% 834
2021
Q2
$665K Buy
5,350
+1,511
+39% +$180K 0.02% 710
2021
Q1
$506K Buy
3,839
+24
+0.6% +$3.29K 0.02% 762
2020
Q4
$505K Buy
3,815
+161
+4% +$19.5K 0.02% 687
2020
Q3
$373K Sell
3,654
-475
-12% -$41K 0.01% 710
2020
Q2
$359K Buy
4,129
+12
+0.3% +$959 0.02% 714
2020
Q1
$239K Buy
4,117
+393
+11% +$31.9K 0.01% 725
2019
Q4
$344K Sell
3,724
-1,094
-23% -$96.2K 0.01% 729
2019
Q3
$435K Buy
4,818
+1,188
+33% +$135K 0.02% 625
2019
Q2
$428K Sell
3,630
-482
-12% -$48.6K 0.02% 599
2019
Q1
$356K Sell
4,112
-968
-19% -$82.4K 0.02% 618
2018
Q4
$321K Sell
5,080
-192
-4% -$13.2K 0.02% 581
2018
Q3
$416K Buy
5,272
+150
+3% +$9.78K 0.02% 549
2018
Q2
$306K Hold
5,122
0.02% 642
2018
Q1
$207K Hold
5,122
0.02% 764
2017
Q4
$269K Sell
5,122
-1,134
-18% -$60.5K 0.02% 655
2017
Q3
$295K Buy
+6,256
New +$252K 0.02% 613

Other funds holding EXAS

Sigma Planning Corp's EXAS Position: Q1 2022 in Review

Sigma Planning Corp sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 3,199 shares — an estimated $249K sold.

Sigma Planning Corp first reported a position in EXAS in Q3 2017 and held it in 18 quarters. The position peaked at $665K in Q2 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Sigma Planning Corp reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • Sigma Planning Corp sold 3,199 Exact Sciences shares in Q1 2022, an estimated $249K.
  • Sigma Planning Corp first reported a position in Exact Sciences in Q3 2017 and held it in 18 quarters.
  • Sigma Planning Corp's Exact Sciences position peaked at $665K in Q2 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Sigma Planning Corp's 13F filing for Q1 2022, filed 20 Apr 2022.